magrolimab
FDA slaps hold on trials of Gilead’s CD47 drug magrolimab
Phil Taylor
blood cancer, Gilead Sciences, immuno-oncology, magrolimab, Oncology, safety
0 Comment
X
FDA slaps hold on trials of Gilead’s CD47 drug magrolimab
https://pharmaphorum.com/news/fda-slaps-hold-on-trials-of-gileads-cd47-drug-magrolimab/
News/ News/ News/ Oncology/ R&D
Gilead trumpets data with newly-bought magrolimab in blood cancers
Phil Taylor
acute myeloid leukaemia, ASCO 2020, Gilead Sciences, immuno-oncology, magrolimab, myelodysplastic syndrome
0 Comment
X
Gilead trumpets data with newly-bought magrolimab in blood cancers
https://pharmaphorum.com/news/gilead-magrolimab-blood-cancer-asco/